FOLFOX-肝动脉灌注化疗联合应用仑伐替尼和程序性死亡受体1 抑制剂治疗中晚期肝癌
徐军红， 姚红兵， 王雪尧， 郭威， 陆才进， 吴嘉兴… - 实用医学杂志, 2024 - syyxzz.com
… safety of nivolumab (PD-1 inhibitor)in combination with lenvatinib and FOLFOX regimen [5-…
and advanced hepatocellular carcinoma (HCC)via hepatic arterial infusion chemotherapy (…
and advanced hepatocellular carcinoma (HCC)via hepatic arterial infusion chemotherapy (…
TACE 联合TKI 及PD-1 抑制剂在不可切除肝细胞癌患者转化治疗中的疗效
韦滔， 唐置鸿， 韦猛， 林有智， 陈洁， 白涛， 王小波… - 中国癌症防治 …, 2021 - zgazfz.com
… with TKI and PD⁃1 inhibitors were collected and … TACE combined with TKI and PD⁃1
inhibitors may be an effective and safe conversion therapy strategy for unresectable hepatocellular …
inhibitors may be an effective and safe conversion therapy strategy for unresectable hepatocellular …
肝动脉灌注化疗联合仑伐替尼及PD-1 抑制剂治疗晚期肝癌后消化道多处穿孔一例
刘张， 苑珠， 李慧龙， 莫嘉强， 彭建新 - 肝胆胰外科杂志, 2024 - gdy.qk.wmu.edu.cn
… Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors plus Lenvatinib
versus PD-1 inhibitors plus Lenvatinib for advanced hepatocellular carcinoma[J]. Front Oncol, …
versus PD-1 inhibitors plus Lenvatinib for advanced hepatocellular carcinoma[J]. Front Oncol, …
[HTML][HTML] 重视介入与靶向和免疫联合治疗在中晚期肝细胞癌中的应用前景
章浙伟， 邵国良 - 实用肿瘤杂志, 2022 - xml-data.org
… ),肝动脉灌注化疗(hepatic artery infusion chemotherapy,HAIC),局部消融… Especially, the
combination of targeted therapy and … inhibitor,TKI)联合程序性死亡受体1(programmed death-1,PD-…
combination of targeted therapy and … inhibitor,TKI)联合程序性死亡受体1(programmed death-1,PD-…
免疫治疗3.0 在晚期胆道癌中的应用
张婷， 赵海涛 - 中国癌症防治杂志, 2023 - zgazfz.com
… ,肝动脉持续灌注化 疗(hepatic artery infusion chemotherapy,HAIC)和射频 消融(radiofrequency …
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine …
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine …
多纳非尼联合HAIC 和信迪利单抗治疗伴下腔静脉癌栓的肝细胞癌并完全缓解-例.
张伟， 高炜， 刘晨， 刘潇濛， 张钦 - Tianjin Medical Journal, 2023 - search.ebscohost.com
… of hepatic artery infusion chemotherapy combined with targeted and immunotherapy on
hepatocellular … Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially …
hepatocellular … Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially …
PD-1/PD-L1 抑制剂在肝癌免疫治疗中的研究进展.
宁苑灵， 林娟娟， 梁建敏 - Practical Pharmacy & Clinical …, 2023 - search.ebscohost.com
… Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors plus lenvatinib
versus PD-1 inhibitors plus lenvatinib for advanced hepatocellular carcinoma[J]. Front …
versus PD-1 inhibitors plus lenvatinib for advanced hepatocellular carcinoma[J]. Front …
免疫联合靶向治疗在晚期肝癌转化治疗中的研究进展
黄沾任， 宁金月， 李汉卿， 陈念平 - 岭南现代临床外科, 2022 - lingnanwaike.com
… inhibitors combined with antiangiogenic targeted drugs and hepatic arterial infusion
chemotherapy… efficacy,bringing hope to patients with advanced liver cancer. At present,immunization …
chemotherapy… efficacy,bringing hope to patients with advanced liver cancer. At present,immunization …
[HTML][HTML] 不可切除肝细胞癌(CNLC-IIIb 期肺转移) 行转化治疗后成功切除一例并文献复习
窦港， 苏强， 杨凯帆， 白亮亮 - Advances in Clinical Medicine, 2024 - hanspub.org
… , the patient was treated with tilelizumab and lenvatinib for 4 cycles, and the tumor volume …
受体1 (Programmed Death 1, PD-1)抑制剂联合酪氨酸酶抑制剂(Tyrosine Kinase Inhibitor, TKI)…
受体1 (Programmed Death 1, PD-1)抑制剂联合酪氨酸酶抑制剂(Tyrosine Kinase Inhibitor, TKI)…
[HTML][HTML] 肝细胞癌伴门静脉癌栓的综合治疗进展
杜常杰， 伍红宇， 李金政 - Advances in Clinical Medicine, 2024 - hanspub.org
… Hepatocellular carcinoma (HCC) combining with portal vein … 和肝动脉灌注化疗(Hepatic
arterial infusion chemotherapy, HAIC).… 剂(Immune checkpoint inhibitors, ICIs)是包含了PD1,PD-L1,…
arterial infusion chemotherapy, HAIC).… 剂(Immune checkpoint inhibitors, ICIs)是包含了PD1,PD-L1,…